If you are reading this because a DEA Order to Show Cause (OSC) just arrived, you already know what is at stake: your patients or customers, your staff, your livelihood, years of work. The OSC tells you that you have thirty days. What it does not tell you is what those thirty days mean, or what deserves your attention while they run.
This article walks through five things worth understanding in the first thirty days.
What You Are Holding, and Why It Reads the Way It Does
An OSC is the document the Drug Enforcement Administration uses to initiate formal administrative proceedings to revoke or suspend an existing DEA registration or to deny a pending application. It is not a criminal charge, but the practical stakes are difficult to overstate. For a healthcare prescriber, a pharmacy, a drug distributor, or a pharmaceutical manufacturer, the registration is often the license on which the entire practice or business runs.
It Is a One-Sided Document, by Design
If the OSC feels overwhelming on a first read, it helps to understand what you are actually reading. An OSC is a one-sided document. It was drafted by the DEA’s lawyers at the end of an investigation that may have run for months, built on prescribing or dispensing data, records pulls, and often the conclusions of a retained expert, all summarized in language chosen to support the Agency’s case.
Nothing in it reflects your side. Your explanations, your records, your patients, and the clinical or business judgment behind the conduct described have not been heard yet. That is not a reason for despair. It is the reason the next thirty days matter. Skilled counsel’s first work in these cases is to correct the record and begin building the defense the OSC never mentions, and the sooner that work starts, the more room there is to do it well.
The Allegations Are a Preview of the Hearing
The allegations themselves deserve a careful read for a reason that goes beyond understanding the accusations. The OSC will identify the statutory grounds DEA is invoking and set out the factual allegations: specific prescriptions, specific patients identified by initials, specific dates, and specific state and federal provisions DEA contends were violated. As a general matter, the scope of any eventual hearing is framed by the allegations in the OSC together with the parties’ prehearing filings. See, e.g., CBS Wholesale Distributors, 74 Fed. Reg. 36,746, 36,750 (2009). The document in front of you is not just a summary of the government’s theory. It is a preview of the hearing to come.
The Public Interest Factors, and the Two That Decide Most Cases
An OSC may invoke several statutory grounds. For prescribers and pharmacies, the most common battleground is the “public interest” standard: DEA may seek to revoke an existing registration on that ground under 21 U.S.C. § 824(a)(4), or to deny a pending application under 21 U.S.C. § 823(g)(1). Either way, the same five factors in section 823(g)(1) govern, for individual prescribers and pharmacies alike, and DEA weighs them in the disjunctive: it can rest its decision on some and give others no weight at all.
In practice, most cases are built and fought on two of those factors: your experience in prescribing, dispensing, or otherwise handling controlled substances (Factor B) and your compliance with laws relating to controlled substances (Factor D). If your OSC recites individual prescriptions alongside citations to state and federal prescribing or dispensing requirements, that is Factors B and D at work.
Manufacturers and distributors have their own public interest factors in other subsections of section 823, and those cases typically allege a failure to maintain effective controls against diversion, conduct that DEA views as also demonstrating negative past experience in manufacturing or distributing controlled substances.
If your matter began earlier in the process, with a records request rather than a charging document, I have covered that stage separately in my discussion of DEA administrative subpoenas, and I have collected answers to common questions in the firm’s DEA defense FAQs.
With that context, here are the five things.
1. You Have Thirty Days, and Silence Is an Admission
Under 21 C.F.R. § 1301.43, you have thirty days from receipt of the OSC to file a request for a hearing before a DEA Administrative Law Judge (ALJ), along with an answer to the allegations. The DEA ALJ’s jurisdiction over the case attaches only when a timely hearing request is filed. See generally 21 C.F.R. §§ 1301.43, 1316.47, 1316.52.
The regulations treat a missed deadline severely. Fail to file a timely request and answer, and you may be deemed in default, which operates as a waiver of the hearing and an admission of the factual allegations in the OSC. 21 C.F.R. §§ 1301.43(c), (e). From there, DEA may proceed to a final order without ever hearing your side.
Extensions May Be Possible, But Do Not Count on One
In limited circumstances, a DEA ALJ may permit an extension of the deadline or accept a late filing supported by good cause. See 21 C.F.R. §§ 1301.43(d), 1316.47(b); Shannon L. Gallentine, D.P.M., 76 Fed. Reg. 45,864 (2011). But whether that relief is available is intensely fact-specific, and it is not generally something to count on. The safer course is to treat the thirty days you were given as the thirty days you have, and to consult counsel as soon as practicable.
2. Check Your Registration’s Expiration Date Today
This is the quieter deadline, and it is easy to miss while the thirty-day clock is running. Your DEA registration has its own expiration date, and an OSC does not pause it. If the registration lapses in the middle of the proceeding, you may find yourself fighting over a registration that no longer exists. The regulations offer a safety net, but it has a catch: under 21 C.F.R. § 1301.36(i), if you apply for renewal at least 45 days before the expiration date and the Administrator has not ruled on that application by the time the registration is due to expire, the existing registration automatically stays in effect until the Administrator acts. File late, and that automatic protection is gone.
The same regulation gives the Administrator discretion to extend a registration even where the renewal application was not filed 45 days ahead, with or without a request from the registrant, upon a finding that the extension is not inconsistent with the public health and safety. But that is discretionary relief, and not something to count on.
How an expiring registration interacts with a pending OSC is a fact-specific question, and one worth raising with counsel early rather than discovering later. Consider checking the expiration date on your Certificate of Registration as soon as practicable.
3. A Corrective Action Plan Is an Option, Not an Escape Hatch
The OSC will also advise you of a second track: the opportunity to submit a corrective action plan (CAP) under 21 U.S.C. § 824(c)(2)(C), asking DEA to discontinue or defer the proceeding based on remedial steps you have taken or propose to take.
Two points about this option tend to matter in practice. First, submitting a CAP is not a substitute for requesting a hearing. The two tracks run separately, and a CAP submitted without a timely hearing request does not preserve your right to contest the allegations. The OSC generally makes clear on its face that submitting a CAP neither stays nor extends the thirty-day deadline to request a hearing.
Second, the CAP is not reviewed by the DEA ALJ who will hear your case. The OSC generally directs that any CAP be submitted to DEA’s Diversion Control Division, which makes its own determination on the plan, independent of the case proceeding before the DEA ALJ.
Whether to submit a CAP, and what it should say, is one of the most consequential decisions you will face in the early days of your case, and in my experience it is worth making deliberately rather than reflexively, with a clear view of how a CAP may be received on the other side and how it serves your broader defense.
4. This Is Not the Trial You Are Picturing
If you request a hearing, your case will be heard by a DEA ALJ, not a jury, and the proceeding will not look like the trials you know from courtrooms or television. Some of the differences work in your favor. Others reward the side that prepares earliest. Four of them are worth understanding now.
The Government Must Prove Its Case, and Its Case May Have Flaws
The burden is on the government. It must come forward with the evidence and prove its case against you, and that case is not beyond challenge. The OSC you received may rest on flawed assumptions of fact. The government’s expert may have built an opinion on faulty premises, such as records reviewed out of context or a standard of care framed too broadly. The law may have been misapplied to the specific facts of your case. And if the government built its case on your prescribing or dispensing data, the numbers do not speak for themselves; the story the government tells about the data can be tested against the clinical and business reality of your practice.
Which of those flaws exist, if any, in your matter, and how hard to press each one, are judgments where experience and expertise matter. Counsel who has built these cases can thoughtfully discern where the government’s case may be vulnerable.
Remedial Measures Can Be Part of Your Case
Your defense is not limited to disputing the allegations. You can also present remedial measures: the steps you have taken since the events described in the OSC, such as compliance reviews, updated policies and procedures, additional training, or changes to how your practice, pharmacy, or business prescribes, dispenses, or handles controlled substances. Those remedial measures can be a meaningful part of your defense.
How remedial measures are presented matters as much as the measures themselves, because they do not stand alone; DEA reads them together with what you acknowledge about the past. Framed well, they show an operation that has confronted its problems and changed. Framed carelessly, they can read as excuses, or as minimizing what happened, and remediation that reads that way tends to carry little weight. Striking that balance is a strategic decision, and one worth making with counsel from the start.
Discovery Is Limited: You See the Government’s Case on DEA’s Schedule
Do not expect the government to show you its case early. Unlike civil or criminal litigation, there are no depositions as of right and no broad document requests. Much of what you learn about the government’s evidence arrives in its prehearing statement and in the exhibits exchanged in the run-up to the hearing, on DEA’s schedule. See Nicholas A. Sychak, 65 Fed. Reg. 75,959, 75,961 (2000). That puts a premium on preparation and on building a strong, compelling defense from the earliest days rather than waiting for the government to show its hand.
The Government Can Rely on Hearsay To Make Its Case, and Pushing Back Matters
Yes, the government can use hearsay against you. The Federal Rules of Evidence do not strictly govern these proceedings, and the DEA ALJ has broad discretion to admit hearsay.
But getting evidence in is not the same as getting it believed. DEA hearings are formal, on-the-record proceedings governed by the Administrative Procedure Act, which requires that an Agency final order rest on reliable, probative, and substantial evidence. Agency precedent leaves room to contest what the government’s evidence is actually worth. And the record you build matters beyond the hearing room: the ALJ’s recommended decision, the Administrator’s final order, and any eventual appeal all rest on the record made at the hearing, so a challenge never raised may be difficult to raise later. Knowing which challenges to press and how to preserve them is one of the places where experienced counsel makes the difference.
5. Consider How You Communicate With DEA, and What Else May Be in Play
The instinct to call the investigators or DEA counsel and explain is understandable. You have likely spent your career cooperating with regulators, and staying quiet can feel unnatural, even like an admission of something. It is neither. Once an OSC has been issued, communications with DEA are communications with a litigation opponent, and statements made without a strategy can be difficult to walk back. If context should be provided, it is often better to weigh it with counsel first: what to convey, when, and how.
A DEA proceeding also rarely stays contained. The outcome can reach state licensing boards, hospitals, and payors through their own rules, and if you are a prescriber enrolled in Medicare, suspension or revocation of your DEA registration is itself a ground on which the Centers for Medicare & Medicaid Services may revoke your enrollment. That is one more reason that what is said, conceded, or negotiated in your DEA matter deserves care from the start.
An Immediate Suspension Order Raises the Stakes
An Immediate Suspension Order (ISO) is generally combined with the OSC in a single document. DEA may issue an ISO only upon finding an imminent danger to the public health or safety, a standard Congress has defined by statute to require a substantial likelihood of an immediate threat that death, serious bodily harm, or abuse of a controlled substance will occur absent the suspension. See 21 U.S.C. § 824(d).
Two features make ISOs uniquely demanding. First, the suspension takes effect the moment it is served: your authority to handle controlled substances under that registration stops that day, and the DEA ALJ has no authority to review or stay it. Second, the suspension ordinarily remains in effect through the conclusion of the proceedings, including judicial review, unless DEA withdraws it or a federal court dissolves it. And because an ISO carries collateral consequences of its own, even an expiring registration does not necessarily bring the case to an end.
If an ISO is part of your matter, the timeline compresses from weeks to days. Contesting one raises its own set of questions, including whether and how to seek intervention in a federal district court while the administrative case proceeds. Those options deserve their own article, which I will publish and link here separately.
Why Experienced Counsel Matters Here
These proceedings move fast. Once a hearing request is filed, the schedule compresses quickly, prehearing filings lock in witnesses and theories early, and the choices you make in the first thirty days echo through the rest of your case. DEA administrative litigation is also a specialized practice, with its own body of precedent, its own burden structure, and its own rhythms, and general litigation experience does not automatically translate. An experienced DEA regulatory defense attorney who has gone the distance in OSC litigation and DEA enforcement matters can be the differentiator in thinking carefully through your options while there is still time to exercise them.
I spent years on the other side of these proceedings. As DEA Diversion Enforcement Counsel in DEA’s Office of Chief Counsel, I drafted OSCs and litigated the enforcement actions they initiated. That experience informs how I read every OSC a client brings me today, and it helps define the defense strategy from the outset, because the early decisions in these cases—what to contest, what to negotiate, and how to position the defense—can shape the trajectory and outcome of everything that follows.
Jani Law PLLC: DEA Defense for the Proceeding That Decides Your Registration
If you have received an Order to Show Cause or an Immediate Suspension Order, the most valuable thing you can do in the first days is get informed. The initial consultation at Jani Law PLLC is free, confidential, and available by phone, video, or in person. Call 202-899-2711 or contact Jani Law PLLC online.
Dhairya Jani is the founder of Jani Law PLLC, a former DEA Diversion Enforcement Counsel, and a former U.S. Department of Justice Trial Attorney. Jani Law PLLC represents DEA registrants nationwide in Order to Show Cause and Immediate Suspension Order proceedings, from settlement negotiations with DEA, through contested administrative hearings before DEA Administrative Law Judges, to appeals of DEA final orders in the U.S. Courts of Appeals. Learn more about Dhairya Jani.
This post is for general information only and is not legal advice. Reading it does not create an attorney-client relationship.